Pitney Bowes (PBI): It's moved a lot but I like the business, said Cramer. I think it can go higher, yet.
Seadrill (SDRL): Other companies in the space are talking about weakness in the platform business, said Cramer. Therefore, I'm not sure the stock has a lot of upside.
Thermo Fisher Scientific (TMO): I'm a buyer, said Cramer. I like it.
Arena Pharmaceuticals (ARNA): I'm not in love with it, said Cramer. It's just not one of my favorites. I'd much rather own Regeneron, Celgene, Biogen or Gilead. In fact, I'd rather own Seattle Genetics and Isis, too.
DexCom (DXCM): I really like this company, said Cramer. It's a fine spec.
Priceline (PCLN): Earnings were very good, said Cramer. I like it.
Call Cramer: 1-800-743-CNBC
Questions for Cramer? email@example.com
Questions, comments, suggestions for the "Mad Money" website? firstname.lastname@example.org